Presentation

Early detection of serious diseases gives healthcare providers better opportunities to make well-informed decisions. Through diagnostic tests that provide relevant information at the right time, treatments can be adapted to the patient’s needs and the progression of the disease.

IDL Diagnostics’ vision is to save more lives through better and earlier diagnostics. We offer rapid tests, laboratory tests and automated platform tests that help healthcare providers identify and monitor serious diseases. By combining high quality, extensive experience and close collaboration with customers and partners around the world, we contribute to better decision-making in healthcare and improved patient outcomes.

IDL Biotech has been present in Indonesia for 20 years, offering our bacteriology portfolio through our distributor network. By providing reliable diagnostic tools, we have consistently supported healthcare professionals in delivering accurate and timely diagnosis, enhancing patient care and treatment outcomes.

IDL Diagnostics has been present in Indonesia for 20 years, through its subsidiary IDL Biotech, offering our bacteriology portfolio through our distributor network. By providing reliable diagnostic tools, we have consistently supported healthcare professionals in delivering accurate and timely diagnosis, enhancing patient care and treatment outcomes.
Through strategic partnerships, we have broadened our diagnostic offering to include hormone testing, oncology, infection and inflammation, and cardiac markers. Powered by a single-reader platform, these solutions provide healthcare professionals with stable, scalable, and reliable point-of-care testing.